A Case of Alkaptonuria: Unexplained Arthropathy, Urine Discoloration, and the Importance of Metabolic Clues in Rare Diagnoses
International Journal of Contemporary Medicine · 2025
DOI: 10.37506/07nhcd71 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Contemporary Medicine, 2025. Verfasst von Sidra Afreen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
IntroductionAlkaptonuria is a rare autosomal recessive metabolic disorder caused by homogentisate 1,2-dioxygenase (HGD) deficiency, leading to the accumulation of homogentisic acid (HGA). This condition manifests through dark urine, progressive ochronosis (tissue pigmentation), early-onset arthritis, and may include cardiovascular complications.This case highlights the importance of considering metabolic etiologies in early degenerative joint disease, particularly when accompanied by systemic signs like urine discoloration and scleral pigmentation. It adds to scientific literature by reaffirming that rare diseases can present even in under-resourced settings and require clinical vigilance for early diagnosis and intervention. Patient Concerns and Key Clinical FindingsA young adult male presented with:Urinary changes: Darkening of urine upon standing.Ochronosis:Bluish-black pigmentation of scleraPigmentation of ear cartilage and skin foldsOchronotic arthropathy:Progressive joint pain and stiffnessAffected areas: thoracolumbar and lumbosacral spine, large joints (knees, hips)X-rays revealed: intervertebral disc calcification, joint space narrowingCardiovascular involvement:Evidence of aortic valve calcification on echocardiography DiagnosisClinical Clues:Progressive early-onset arthropathyUrine discolorationVisible pigmentation (ochronosis)Laboratory Findings:Ferric chloride test: Black colorationBenedict’s test: Green to black precipitateGas chromatography–mass spectrometry (GC-MS): Elevated homogentisic acid (HGA)Genetic testing: Mutation in HGD gene confirmed diagnosis Interventions1. Symptomatic Management:NSAIDs for joint pain and stiffnessPhysiotherapy to preserve joint mobility2. Dietary and Medical Support:Low-protein diet to reduce phenylalanine and tyrosine intake (precursors of HGA)Vitamin C supplementation to slow oxidative polymerization of HGA3. Monitoring and Surveillance:Serial imaging to monitor spinal and joint degenerationRegular urinalysis for metabolic monitoring4. Genetic Counseling:Family screening and education about autosomal recessive inheritanceCarrier testing for first-degree relatives5. Orthopedic Referral:For early assessment and management of degenerative joint changes OutcomesAt 3-month follow-up:Joint symptoms moderately improved with NSAIDs and physiotherapyUrine discoloration persistedPatient reported better functional capacity in daily activitiesAdherence to lifestyle and diet modifications was satisfactory Conclusion and Key TakeawaysThink metabolic in unexplained early-onset arthritis—especially when accompanied by systemic clues.Urine discoloration is a simple but underrecognized diagnostic sign of alkaptonuria.Ochronosis, though delayed, is a diagnostic hallmark.Early diagnosis and multidisciplinary care can improve quality of life and delay joint deterioration.Rare diseases occur even in rural or peripheral health settings, emphasizing the need for awareness and basic metabolic workups in atypical arthropathy cases.
Zitieren
APA
Afreen, S. (2025). A Case of Alkaptonuria: Unexplained Arthropathy, Urine Discoloration, and the Importance of Metabolic Clues in Rare Diagnoses. International Journal of Contemporary Medicine. https://doi.org/10.37506/07nhcd71
Vancouver
Afreen S. A Case of Alkaptonuria: Unexplained Arthropathy, Urine Discoloration, and the Importance of Metabolic Clues in Rare Diagnoses. International Journal of Contemporary Medicine. 2025. doi:10.37506/07nhcd71
BibTeX
@article{Afreen2025,
author = {Afreen, Sidra},
title = {A Case of Alkaptonuria: Unexplained Arthropathy, Urine Discoloration, and the Importance of Metabolic Clues in Rare Diagnoses},
journal = {International Journal of Contemporary Medicine},
year = {2025},
doi = {10.37506/07nhcd71}
}
EUVIMED